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Abstract
Vertebrate embryos are derived from a transitory pool of pluripotent cells. By the process of embryonic induction, these
precursor cells are assigned to specific fates and differentiation programs. Histone post-translational modifications are
thought to play a key role in the establishment and maintenance of stable gene expression patterns underlying these
processes. While on gene level histone modifications are known to change during differentiation, very little is known about
the quantitative fluctuations in bulk histone modifications during development. To investigate this issue we analysed
histones isolated from four different developmental stages of Xenopus laevis by mass spectrometry. In toto, we quantified 59
modification states on core histones H3 and H4 from blastula to tadpole stages. During this developmental period, we
observed in general an increase in the unmodified states, and a shift from histone modifications associated with
transcriptional activity to transcriptionally repressive histone marks. We also compared these naturally occurring patterns
with the histone modifications of murine ES cells, detecting large differences in the methylation patterns of histone H3
lysines 27 and 36 between pluripotent ES cells and pluripotent cells from Xenopus blastulae. By combining all detected
modification transitions we could cluster their patterns according to their embryonic origin, defining specific histone
modification profiles (HMPs) for each developmental stage. To our knowledge, this data set represents the first
compendium of covalent histone modifications and their quantitative flux during normogenesis in a vertebrate model
organism. The HMPs indicate a stepwise maturation of the embryonic epigenome, which may be causal to the progressing
restriction of cellular potency during development.
Citation: Schneider TD, Arteaga-Salas JM, Mentele E, David R, Nicetto D, et al. (2011) Stage-Specific Histone Modification Profiles Reveal Global Transitions in the
Xenopus Embryonic Epigenome. PLoS ONE 6(7): e22548. doi:10.1371/journal.pone.0022548
Editor: Ferenc Mueller, University of Birmingham, United Kingdom
Received January 26, 2011; Accepted June 29, 2011; Published July 22, 2011
Copyright:  2011 Schneider et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: Funding was provided by the Fo ¨FoLe-program "Molecular Medicine" of the medical faculty/LMU Munich to T.S. (project-# 61/2006), by grants from the
European Union to A.I. (LHSG-CT2006-037415), and by the Deutsche Forschungsgemeinschaft to A.I. (SFBTR5/M4) and RR (SFBTR5/M5). The funders had no role in
study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: ralph.rupp@med.uni-muenchen.de (RAWR); Axel.Imhof@med.uni-muenchen.de (AI)
Introduction
The packaging of DNA into chromatin plays an important role
in setting up specific gene expression patterns during early
embryonic development. The level of packaging is regulated by
specific histone modifications leading to a more open or closed
chromatin structure, depending on the factors that bind to the
specific modifications. Recently, several genome wide mapping
studies have revealed specific distribution patterns of particular
modifications [1]. For example, H3 Lys-4 (i.e. H3K4) is often
found methylated at cis-regulatory elements such as enhancers and
promoters, and a combinaton of di-/trimethylated K4 at the
promoter and K36 in the transcribed gene body, respectively,
indicates reliably active transcription units. In contrast, methyla-
tions at H3K9 and H3K27 correlate with repressed domains.
Under specific circumstances, chromatin fragments have been
identified that simultanously carry active as well as repressive
modifications, specifically the H3K4me3 and H3K27me3 marks.
This chromatin state has been termed bivalent to indicate its
ambiguous nature [2,3,4,5]. Bivalent domains first have been
described in embryonic stem (ES) cells, where they may keep
developmental regulatory genes in a state poised for subsequent
activation during cellular differentiation. However, bivalent
domains are not restricted to pluripotent cells and most likely
have functions beyond priming genes for activation [6]. Altogeth-
er, these genome wide studies indicate covalent histone modifica-
tions as important regulatory components of development and
cellular differentiation.
A growing body of data suggests that histone modifications
convey important information to early developmental programs in
mammals. Histone modification patterns in gametes become
established during germ cell differentiation [7], and nucleosomes,
which are retained in low numbers in human sperm, carry histone
modifications on particular developmental loci [8]. This finding
extends to zebrafish, who packages its sperm genome entirely into
nucleosomes, rather than protamines [9]. After fertilisation,
widespread epigenetic reprogramming, occuring in cooperation
with stochastic gene expression of lineage-determining transcrip-
tion factors, helps prepare the earliest lineage decisions that
generate trophectoderm, primitive endoderm and inner cell mass
(reviewed in detail in refs. [10,11,12]).
Our knowledge about the epigenetic changes, which accompa-
ny the determination of definitive somatic cell lineages in the
mammalian embryo, are derived largely from in vitro differenti-
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characterized by a derepressed chromatin structure that is highly
permissive to the transcriptional machinery [13]. The chromatin
structure and function of ES cells changes dramatically during
differentiation. For instance, the number and size of heterochro-
matic foci, visualized by immunostaining for heterochromatin
protein 1 (HP1), increase upon differentiation [14]. FRAP
(fluorescent recovery after photo-bleaching)-analysis revealed that
HP1 as well as core and linker histone proteins are hyper-
dynamically bound to chromatin in the undifferentiated ES cell,
but are more stably associated with chromatin upon differentia-
tion. These changes extend also to covalent histone modifications.
Examples are the differentiation-dependent increase in the
repressive mark tri-methylated Lys-9 of histone H3 (H3K9me3),
and the observed decrease in the global levels of acetylated
histones H3 and H4 [14]. ES cells, differentiated under retinoic
acid administration, undergo a two-fold reduction of H3K4me2
levels, while H3K9me1 and H3K79me2 levels increased moder-
ately, describing nearly specific histone modification patterns for
undifferentiated ES cells and their differentiated progeny [15].
Striking changes in histone methylation and acetylation during
human ES cell differentiation have also been observed by mass
spectrometry for the aminoterminal tail domain of histone H4
[16]. Overall, this data shows that the fraction of nucleosomes with
repressive histone marks increases during ES cell differentiation,
reflecting the lineage-specific use of the genome in somatic cells.
Interestingly, direct reprogramming of somatic cells to an induced
pluripotent state reverses these changes largely, although not
completely. During reprogramming, histones become hyper-
methylated at H3K4, bivalent domains are re-established, while
repressive marks are diminished, indicating a general shift towards
the transcriptionally permissive chromatin of pluripotent ES cells
[17]. Thus, transitions between pluripotent and comitted somatic
cell fates during development or reprogramming involve global
alterations in histone-modifications.
Pluripotent ES cell lines are established and maintained under
stringent culture conditions. Although being derived from
endogenous pluripotent cell populations, they have no strict
counterpart in vivo [12]. Indeed, derivation of ES cells from the
blastocyst inner cell mass causes a significant skewing of histone
modification patterns, including H3K4 and H3K27 methyl marks,
compared to the inner cell mass [18]. The many cell types and
tissues of the mammalian embryo arise from the epiblast after
implantation, and very little is known about histone modifications
at this time of development. Results from carrier ChIP analysis on
microdissected tissues from post-implantation mouse embryos
suggest that genes known to be bivalently marked in ES cells tend
also to be enriched for these modifications in embryonic tissues
[19]. However, the bivalent status of these genes has not been
rigorously established by sequential ChIP analysis and, thus, the
opposing marks could be distributed between cells in a non-
overlapping manner.
Other vertebrate model organisms such as Xenopus and zebrafish
have recently provided key information on epigenetic changes in
early development. Histone variants and modifications from
various X. laevis cell types including oocytes, sperm and somatic
cells, have been characterized by immunoblotting and mass
spectrometry, indicating unique histone modification signatures
for each cell type [20,21]. While these studies did not analyse
chromatin from normal embryos, genome-wide RNA-Seq and
ChIP-Seq technologies were combined to investigate histone
modifications in the course of X. tropicalis development [22]. This
revealed a hierarchical acquisition of H3K4me3 and H3K27me3
marks, following the onset of zygotic transcription at midblastula.
Specifically, spatial differences in the deposition of the repressive
Polycomb mark H3K27me3 was predicitve of localized gene
expression patterns. In contrast to mammalian ES cells, bivalent
chromatin domains are practically absent from Xenopus embryos
[22]. Lysine trimethylation of H3K4 and H3K27 appears in the
zebrafish epigenome only after the maternal-zygotic transition and
in the same sequence as in frogs. However, sequential chromatin
immunoprecipitation revealed the existence of bivalent chromatin
domains in the zebrafish [23]. While it is currently unclear,
whether the observed differences for bivalent domains between
frog and fish has a biological basis or reflects technological
differences, these studies have provided evidence of genome-wide
transitions in histone modifications during normal vertebrate
development.
The information from ChIP-based studies is invariably dictated
by many technical parameters, most notably the antibody quality
(discussed in [24]). We have sought to obtain quantitative
information on different histone modifications by an antibody-
independent approach. Here we report the results from mass
spectrometry analysis of histone modifications present in bulk
embryonic chromatin through X. laevis development. This analysis
has revealed major quantitative shifts for several histone
modifications known to be involved in gene regulation, and has
also identified specific differences between pluripotent cells from
frog embryos and murine ES cells. The quantitative shifts, which
we observed during development, cluster into stage-specific
histone modification profiles accompanying and potentially
regulating the transition from pluripotent to determined cell states.
Results
Experimental design
In order to investigate histone post-translational modifications
(PTM) during vertebrate embryogenesis, we purified core histone
proteins from unmanipulated X. laevis embryos of four different
developmental stages (Figure 1A). The stages included blastula
(Nieuwkoop Faber stage NF9), gastrula (NF12), neurula (NF18)
and tadpole (NF37) embryos [25], representing key steps in
vertebrate development. At late blastula, shortly after the onset of
zygotic transcription, embryos consist mostly of uncomitted,
pluripotent cells (refs. [26,27]; Nicetto and Rupp, unpublished
data). By the gastrula stage, the germ layers have been induced,
and embryonic patterning increases the cellular diversity of the
embryos during neurulation [28,29]. After hatching, tadpoles are
composed largely of differentiated, although premetamorphic,
somatic cells [25].
To evaluate the results from the embryonic samples, we also
preparedhistonesfrom XenopusA6andXTC-2cell lines,aswell as
from murine germline-transmission competent GS-1 ES cells
[30,31] and primary embryonic fibroblasts (MEF). The identity of
the histone molecules was determined by mass spectrometry.
Alignment of the primary sequences of Xenopus histones with core
histones of other species such as human, mouse and fruitfly revealed
high interspecies conservation of the H3 and H4 histones (Figure
S1). Overall, we obtained a sequence coverage of 68.9% for H3 and
87.3% for H4 (Figure S2 and data not shown), covering most of the
known histone modification sites on these histones [32,33].
Therefore, we focused our further investigations on canonical,
replication-dependent histone H3 and on histone H4.
Histone Modification Analysis and Quantification using
LC-MS/MS
For the identification of histone post-translational modifications
we preferentially used high mass accuracy LC-MS/MS mass
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and H4 were separated by SDS-PAGE, covalently modified by
propionic anhydride and subsequently digested by the endopro-
tease trypsin [34] (see Figure 1B). The resulting peptides were then
separated by C18 reversed phase chromatography, subjected to
tandem mass spectrometry and quantified by integrating the area
under the extracted ion chromatogram (XIC) of the corresponding
doubly and triply charged ions. When we analysed the
chromatographic behaviour of differentially modified peptides,
we detected a specific shift of retention times depending on the
type of modification. Specifically, acetylation of the H4 peptide
amino acids 4-17 leads to an earlier elution by approximately 0.7
minutes (Figure 1C). From these findings we concluded that in
addition to the mass of a histone peptide and its fragmentation
spectrum, the elution time is also a unique parameter to
characterise the modification of a peptide. In the following
analysis we therefore used the retention time as a third parameter
to determine the identity of a given peptide. The small mass and
specific biochemical characteristics of two peptides, i.e. histones
H3 peptide 3–8 and H4 peptide 20–23, precluded analysis by LC-
MS/MS, and, therefore, were analysed by conventional MALDI-
TOF mass spectrometry to investigate their modification states.
Overall, we monitored 18 known modification sites (17 lysine
residues, one serine residue) that are present on five peptides of H3
and four peptides of H4, respectively (Tables S1 and S2). Quite often,
the type or extent of modification on a particular site is known to be
associated with different biological functions. For instance, the Lysine
residue at position 27 of H3can be unmodified or acetylated, which is
compatiblewith transcriptional activity;alternatively,itcanbemono-
, di- or trimethylated, indicating an increasing activity by Polycomb,
which leads to transcriptional repression. Furthermore, the fragmen-
tation of propionylated histones generates in some cases peptides,
which contain more than one modification site (e.g. peptide 4–17 on
H4; see Tables S1, S2, S3 and S4), allowing us to detect some
combinatorial modification states that coexist on single peptide
molecules. Based on the potential biological implications we view
each unambigously identified mass shift as a distinct modification
state. Based on this definition, we have characterized in toto 59
different modification states by either LC-MS/MS (52 states; Tables
S3 and S4) or by MALDI/TOF (7 states). For each developmental
stage we quantified spectra from two (tandem LC-MS/MS) or three
(MALDI-TOF) biological replicates, with an average correlation
coefficient of 0.9962 between biological replicates, indicating high
robustness for the reported epigenetic states.
Active marks
As described above, we detected multiple acetylation states at
the aminoterminal tail of histone H4 (Figures 1C and 2B). Similar
to what has been described in other organisms [35,36], the mono-
acetylated peptides are predominantly modified at Lysine 16
(Figure 2A). In blastulae, 38% of the total H4 4–17 peptides carry
a single acetyl group. The level of mono-acetylation rises in later
developmental stages to a steady state of more than 40%
abundance (see also Table S2). The percentage of mono-
acetylation is slightly lower in tissue culture cells (38% in A6 and
34% in XTC-2, respectively; Figure S3, panel A), which instead
contain more unmodified peptide (54% in A6 and 58% in XTC-
2). Of the many potential di-acetylated forms we detected only two
states, i.e. simultanous acetylation of either K5 and K12, or K8
and K16. K5/K12 di-acetylation is quite abundant at the blastula
stage (27%, Figure 2A). Since this modification state is known as a
hallmark of predeposition histones [35,37,38], this pool probably
reflects maternally stored H4 molecules. This modification state
was neither detected on histones from later stages nor on histones
isolated from frog cell lines. From gastrula stage onwards, we
detected a wave of K8/K16 diacetylated H4 in the embryo,
increasing from 11% at NF12 to 17% at NF18, before decreasing
again to 11% at NF37 (Figure 2A). The frog cell lines contain
somewhat lower levels of K8/K16 di-acetylated H4 (appr. 7%,
Figure S3A). The tri- as well as the tetra-acetylated isoforms are
less abundant in all embryonic stages (,10%), even though they
were 5-fold higher than in tissue culture lines (,1.5%; compare
Figure 2A and Figure S3A). In case of the tri-acetylated isoform,
all LC-MS/MS spectra point to a specific modification pattern of
acetylation marks at lysines 5, 12 and 16, which argues against a
Figure 1. Histone modification profiling for Xenopus embryo-
genesis. A) Time line of Xenopus laevis embryonic development – NF
stages according to Nieuwkoop and Faber [25] and by hours after
fertilization (hpf). The stages selected for mass spec analysis are
characterized by the following embryonic and cellular features: Blastula
(NF9) naive ´/multipotent cells; Gastrula (NF12) germ layers specified;
Neurula (NF18) germ layer patterning and differentiation; Tadpole
(NF37) embryonic development completed, larvae hatched. B) Flow
chart for quantitative mass spectrometric analysis of histone modifica-
tions from normal X. leavis embryos. C) Elution profile of differentially
acetylated histone H4 4-17 peptides of X. laevis Blastulae from a
reversed-phase C18 micro-column of the LC-MS/MS. Shown are the
extracted ion chromatograms at corresponding retention times (x-axis),
the y-axis represents the intensity of ion currents of the quadrupole
Orbi-Trap mass spectrometer. The areas under the peaks are used for
quantification of different modification states of a peptide. X-axis:
elution time in minutes. Y-axis: intensity of peptides according to ion
current of the quadrupole Mass Spectrometer (unmod = unmodified
peptide, 1Ac = monoacetylated, 2Ac = diacetylated, 3Ac =
triacetylated, 4Ac = quatruple-acetylated peptides, RT = retention
time).
doi:10.1371/journal.pone.0022548.g001
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previously for mammalian histones [39].
On the H3 N-terminus, we find acetylation of K9 and K14. At
low abundance we detected di-acetylated peptides (K9ac + K14ac)
in all stages, however, we were not able to find acetylation of K9
without the acetylation of K14 (Figure 2B). This suggests that K9
acetylation either requires previous acetylation of K14 or occurs
simultanously. The level of mono-acetylation of this peptide
decreases significantly as development proceeds from 45% in
blastulae to 31% in gastrulae, after which it increases again
Figure 2. Histone modifications of cell proliferation and active transcription in Xenopus embryos. Bar-Charts showing the relative
abundance of histone modifications, identified either by Orbi-Trap LC-MS/MS mass spectrometry (A-D; error bars indicate SD of two independent
biological replicates) or MALDI-TOF mass spectrometry (E - error bars indicate SD of three independent biological replicates). Abbreviations: unmod
= unmodified peptide, Kac = acetylated lysine residue, Kme1 = mono-methylated, Kme2 = di-methylated, Kme3 = tri-methylated lysine residue.
Where applicable, p values are given by numbers above brackets to indicate significant differences in the abundance of a histone modification
between samples.
doi:10.1371/journal.pone.0022548.g002
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acetylation, the tissue culture cells contain less acetylated H3
(Figure S3 panel B). Di-acetylated H3 K9/K14 molecules are
much less abundant and their levels do not change significantly
during development. However, the levels are slightly lower again
in the two frog cell lines, compared to blastulae, which contain the
lowest value of the four embryonic stages (1.17%, see Table S1).
In addition to the K9 and K14 residues, the nearby lysines 18
and 23 on the H3 N-terminal tail can also be acetylated. We find a
similar pattern for both mono-acetylated states with a significant
shift between NF9 and the three other embryonic stages
(Figure 2C). Like for the K9/K14 pair, we find K18 acetylation
only in combination with acetylated K23. These levels are
between 4% in NF12 and 9% in NF37. Monoacetylated K23
ranges from 57% in Blastula to 45% in the other embryonic stages.
In the two Xenopus cell lines, the level of K23 mono-acetylation is
around 20% and the di-acetylation at 2% (Figure S3C). Thus, also
for these H3 acetylation marks, the four embryonic samples are
very different from the cultured frog cell lines.
Further inwards of the N-terminal tail, we also detected
acetylation of K27. This Lysine can also be methylated by
PRC2 complexes (see below). Embryonic samples contain
H3K27ac at relatively constant levels of 1–2% (Table S1). This
modification was less abundant in all other samples (#0.54%
(Figure S3, panel I), and among these, ES cells had the lowest
K27ac levels (0.06%; Table S1). These differences, in particular
between frog embryos and murine ES cells, are remarkable, given
that acetylation of K27 is known to antagonize Polycomb silencing
in flies [40], and to mark active enhancers [41].
Besides N-terminal acetylation marks, we also detected
acetylation in the H3 histone-fold domain at Lysine 56
(H3K56ac; Figure 2D). This modification has been suggested to
represent a predeposition mark [42,43,44], and it was shown to be
linked to the core transcriptional network of human ES cells [45].
In mammalian cells increased H3K56ac levels correlate with
tumorigenicity and the undifferentiated nature of cells [46]. In frog
embryos, H3K56ac levels are always low (0,11%–0,32% abun-
dance) and comparable to the levels in the two frog cell lines.
We have also found Lysine-56 to be methylated (predominantly
me1) in both embryos and cultured cell lines at low abundance
(Table S1). Very little is known about this PTM, which has been
detected so far in human and Tetrahymena chromatin [47].
Interestingly, both K56me1 and K56ac levels reach a minimum
at gastrula stages, i.e. when germ layers become specified. MEFs
and murine ES cells contain somewhat higher levels of K56me1
(Table S1). Since this mark has also been observed in Drosphila
embryos (A.I., unpublished), the ability to methylate H3K56
appears to be a conserved feature among metazoa.
The most prominent histone modification associated with
transcriptionally active promotors is di- and tri-methylated lysine
4 of H3 (H3K4me2/me3) [1,48]. In order to analyse the tryptic
peptide 3-8 that contains Lys-4, we used a different de-salting
method that can be applied to very small hydrophilic peptides.
This new method improves the signal to noise ratio significantly,
thereby allowing the quantitation of the differentially modified
isoforms (Figure 2E). We found that the amount of the unmodified
peptide increases significantly during embryonic development
from 27% in NF9 to 44% in NF37. This is largely due to a
decrease in tri-methylation from 28% in NF9 to 16% in NF37.
The levels of the mono- and di-methylated isoforms remain
relatively constant. In comparison, the two cultured frog cell lines
have much higher levels of unmodified (67% in A6 and 62% in
XTC-2), and much lower levels of di- and tri-methylated H3K4
(#10% each; Figure S3, panel F). This data indicates an unusual
and transcriptionally permissive state of the uncomitted blastula
epigenome, in which half of the histone H3 N-terminal tails
appear to be di- or tri-methylated at Lysine 4.
Repressive marks
One of the best characterized modifications that is associated
with heterochromatin and transcriptionally repressed genic
regions is di-/tri-methylation of lysine 9 on the H3 tail. In
contrast, K9 mono-methylation has been associated with regula-
tory DNA elements and maintenance of activation potential
during differentiation [1,49]. In all our samples, we find K9 in
mono-, di- and tri-methylated form, although at very different
levels (Figure 3A). The different modification states of K9 fluctuate
less than two-fold during frog development, except for K9me1,
which shows a small but significant transient peak at gastrula,
when it accounts for 20% of the total H3 9–17 peptides. A similar
distribution of mono-, di- and trimethylated K9 is found also in the
two cultured Xenopus cell lines (Figure S3G). Combined, the
K9me2/me3 marks make up for less than 4% of the total H3 tails
in the different Xenopus samples, suggesting a rather low density of
this mark in both constitutive and facultative heterochromatin.
The tryptic peptide 20-23 from propionylated histone H4 with
the sequence KVLR has one lysine residue at the position 20,
which is known to be methylated. Its different methylation states
have been linked to diverse epigenetic functions. The
H4K20me2/me3 marks are correlated with the formation of
pericentromeric heterochromatin, maintenance of genome integ-
rity and transcriptional repression, while the role of H4K20me1 is
not fully understood (see also review by [50]). Using MALDI-
TOF, we found in all samples peptides corresponding to
unmodified, mono-methylated and di-methylated states
(Figure 3B). The amount of the unmodified peptide decreases
slightly from blastula to tadpole stage, and is even lower in the A6
(20%) and XTC-2 (17%) cell lines. It is known that the specific
properties of the tri-methylated H4 20-23 peptide make it very
difficult to quantify this PTM by mass spec, and we have not
reproducibly detected it in our samples. To determine the relative
abundance of H4K20me3 in frog embryos, we performed Western
blot analysis with antibodies against methylated H4K20 as well as
pan-histone H3. This confirmed the consistent presence of the
H4K20me3 mark during embryonic development (Figure 3C; see
Figure S4 for cultured cells), and revealed also that its abundance
increases appr. five-fold from blastula to tadpole stages.
Opposing marks on the histone H3 27-40 peptide
Methylation of lysines 27 and 36 within the histone H3 tail has
been mapped to mutually exclusive regions within the genome of
most eukaryotes [51]. The H3K27me2/me3 marks are almost
exclusively found at inactive genomic regions, whereas the
H3K36me2/me3 marks are localized predominantly in actively
transcribed genes [1,52,53]. Both modifications reside on the same
tryptic peptide (H3 residues 27–40), which allows us to determine
combinations of modification states on these two lysines by mass
spectrometry. However, as peptides carrying a single trimethyl
group at either K27 or K36, or combinations of a monomethyl
and a dimethyl group at these two lysines, are isobaric (i.e. they
have the same mass), they cannot be distinguished solely by this
parameter (see Figure 4A). Although tandem MS/MS analysis can
facilitate the assignment of the modifications, the relative
quantitation based on extracted ion chromatograms is only
possible when the differentially modified isobaric peptides are
physically separated. Indeed, tandem MS/MS spectra revealed
that most peptides that have a higher methylation degree at
position 27 elute earlier from a C18 reversed phase column than
Global Transitions in Embryonic Epigenome
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groups on K36 (Figure 4B and C). With the exception of the
isobaric mono-methylated peptides (i.e. K27me1 or K36me1),
which were not separated on the C18 micro-column, this
observation enabled us to identify 12 additional, distinct
methylation states for the K27 and K36 positions on single H3
27–40 peptides.
In genome wide studies, tri-methylation of H3K36 is found at
strongly expressed genes, which are also preferentially enriched for
the replication-independent histone variant H3.3 [1,54]. On
canonical histone H3 (i.e. replication-dependent H3.2; ref. [54])
that is highly abundant in early embryos, we have detected
H3K36me3 by its fragmentation spectrum only in frog tadpoles at
very low abundance (see Table S3). Its relative absence from
embryos could be explained, if frogs deposit the K36me3 mark
selectively on the replication-independent H3.3 variant, as has
been reported for murine ES cells [55]. The ratio of H3.3 to H3.2,
as measured by comparing all spectra derived from the peptides
unique for each isoform, decreases during development from 20%
in blastula to approximately 7% in tadpoles (Figure S5). However,
in all cases we find a very similar distribution of modifications
within these peptides, and therefore focused our analysis on the
peptide derived from the more abundant, canonical H3 molecule.
Overall, this data indicates that H3K36me3 levels are low during
frog development.
Consequently, these findings imply that practically all the single
tri-methylated 27–40 peptides of H3 represent K27me3, a
conclusion that is supported by the fragmentation spectra. We
found that H3K27me3 was readily identified in many, but not all
samples. Notably, it was not detected in blastula and gastrula, and
appeared only at very low levels in neurula (0.05%) and tadpole
stages (0.1%; Figure 4, C and D). However, in Xenopus cell lines
(Figure S3, panel I), as well as in mammalian cells (see below),
H3K27me3 levels were at least 100-fold higher than in bulk
neurula chromatin. We conclude that the repressive K27me3
modification is present in our histone extracts, but extremely
underrepresented in the early frog embryo compared to cultured
frog and mammalian cell lines.
Overall, the abundance of methylated H3K27 rises during
development (Figure 4D and E; Table S1). This trend became
particularly obvious, when we compared the XIC profiles of the
di-methylated peptide species. While the K36me2 peak stayed
more or less constant, the K27me2 peak increased gradually from
1.6% in the blastula to 14% in the tadpole stage (Figure 4B and
D). During this time, the ratio of H3K27me2 to H3K36me2
changed from 0.14 in the blastula to 1.6 in the neurula stage, i.e.
Figure 3. Histone Modifications of transcriptionally repressed chromatin and constitutive heterochromatin in Xenopus embryos.
Bar-Charts of repressive lysine methylation states on histone H3K9 and H4K20. A) Data from Orbi-Trap mass spectrometry - error bars: SD of two
independent biological replicates. B) Data from MALDI-TOF mass spectrometry - error bars: SD of three independent biological replicates. C)
Immunoblotting for total Histone H3 and histone H4 trimethylated at lysine 20. Left panel – western blot Odyssey infrared imaging signals; right
panel – bar chart showing increase of H4K20me3 levels relative to total histone H3 protein during development. Abbreviations: unmod =
unmodified peptide, Kac = acetylated lysine residue, Kme1 = mono-methylated lysine residue, Kme2 = di-methylated lysine residue, Kme3 = tri-
methylated lysine residue. Where applicable, p values are given by numbers above brackets to indicate significant differences in the abundance of a
histone modification between samples.
doi:10.1371/journal.pone.0022548.g003
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Figure 4. Opposing Histone Modifications on the H3 27-40 peptide in Xenopus embryos. A) Amino-acid sequence of the H3 27-40 peptide
and its isobaric modification forms, which have identical mass although beeing differently modified at K27 and K36 residues. Panels B+C - Extracted
ion chromatograms (XICs) showing separation of isobaric H3 27–40 peptides from the four Xenopus embryonic stages by differential elution from a
C18 micro-column on the reversed-phase HPLC of on-line mass spectrometry. X-axis represents retention time, y-axis the intensity of ion currents in
the quadrupole Orbi-Trap mass spectrometer. Peak separation was called by the ICIS peak detection algorithm program (Thermo), indicated here by
the vertical black lines. B) XICs of isobaric di-methylated peptides, modified at either K27 or K36. C) XICs of isobaric tri-methylated peptides
representing K27me3/K36me3, K27me2+K36me1 and K27me1+K36me2. D) Bar-Chart of H3K27 and K36 modification states. Note that isobaric mono-
(data not shown) and tri-methylated peptides, which are methylated either at K27 or K36, elute simultanously and cannot be distinguished. E) Bar-
Chart of combinatorial K27/K36-methylated peptides. Abbreviations: unmod = unmodified peptide, me1 = single mono-methylated lysine at
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and XTC-2 showed the highest percentage of H3K27me2
peptides (33% and 22% respectively), and contained more than
10% of H3K27me3 (Figure S1, panel I and Table S3).
The abundance of peptides with combinatorial methylation on
both K27 and K36 residues rises also siginificantly during
development. In the frog blastula, less than 2% of H3 tails are
simultanously modified on these sites, while one third is
combinatorially modified in tadpoles (Figure 4C and E). Among
these, we found also low levels of unexpected combinations such as
K27me3 paired with K36me1/me2 in late embryonic and tissue
culture cell samples (Table S1). In general, the level of
modifications within this peptide shows a major increase during
development. This trend may be connected functionally to the
establishment of stable gene expression profiles as cells differen-
tiate.
Methylation states of pluripotent frog blastulae and
murine ES cells
Most cells in the blastula stage of Xenopus embryos are
uncomitted and capable to differentiate into derivatives of all
three germ layers [26,27]. This raised the issue, whether the
histone modification profiles we observed in the frog blastula
represent common features of pluripotent cells. To address this
point, we continued to analyse the histone PTMs of murine ES
cells and of primary embryonic fibroblasts (MEFs), which were
used as feeder cells in the ES cell culture and represent a murine
somatic cell type for comparison.
When we initially compared MEFs with ES cells, we observed
different degrees of acetylation on the H3 18–26 and H4 4–17
peptides, indicating that we separated successfully ES cells from
MEF feeders (Figure S6). In depth analysis confirmed then that the
two murine cell types contained very specific profiles of histone
modifications, and that the histone modifications of pluripotent
cells from Xenopus blastulae were related to, but also clearly
distinguishable from the profiles of pluripotent murine ES cells
(Tables S1 and S2).
Bivalently marked chromatin fragments, which simultanously
carry the active H3K4me3 and the repressive H3K27me3 marks,
are considered a hallmark of pluripotency [3,4]. With our
technical approach we cannot determine, whether histone H3
tails are modified on both Lysine 4 and 27, since these residues are
located on different tryptic peptides. Nevertheless, we compared
the overall abundance of modifications at these sites. For H3K4,
this comparison revealed a high similarity between Xenopus
blastula and murine ES cells (Figure 5A). Of all samples, these two
contained the lowest amount of unmodified K4 (below 30%), but
maximal amounts of H3K4me2/me3 (.50% together). In
contrast, H3K4me1 levels were not only similar between blastula,
ES cells and MEFs, but almost constant in all samples (Figures 2D
and S3E).
In contrast to H3K4, the methylation profiles of the H3 peptide
27–40, including Lysines 27 and 36, were very different between
blastulae and ES cells. As described earlier, the majority of the di-
methyl marks reside on K36 in frog blastulae. In ES cells,
however, they were found predominantly on K27 (Figure 5B and
D). MEFs had a similar dimethyl-distribution as ES cells, but
contained significantly more K36me2 than these. A dichotomy
was also found for the higher modification states of this peptide,
including three to five methyl groups. Whereas in frog blastulae
H3K27me3 is below the detection limit, mouse ES cells had with
8.3% the third-highest K27me3 abundance of all samples tested,
and twice as much as MEFs (Figure 5C and D). This huge
quantitative difference is also seen in western blots (Figure 5E).
Thus, both mass spec and western blots indicate independently
that the epigenome of ES cells is more than 100-fold enriched for
H3K27me3 compared to frog blastulae.
Combinatorial tri-methylated states, such as K27me1/K36me2
and K27me2/K36me1 were also significantly more abundant in
ES cells than in frog blastulae, and comparable to the levels found
in MEFs. Notably, the highest levels of tetra- (K27me2+K36me2)
and penta-methylated (K27me3+K36me2) states of the H3 27–40
petides were also found in ES cells and to a less extent in MEFs,
but were not detected in frog blastulae (Figure 5E and Table S1).
Except for mono-methyl (K27 or K36) and di-methyl (K36) states,
frog blastulae contain the lowest methylation levels for the H3 27–
40 peptide of all the samples tested.
Overall, these results indicate that frog blastulae and murine ES
cells share high H3K4me2/me3 levels, but the former are
dramatically undermethylated at the H3 27–40 peptide. In fact,
uncommitted frog cells have a 15-fold higher level of the
unmodified state of this peptide than pluripotent GS-1 ES cells.
Based on this, the polycomb repression complex 2 (PRC2) activity
seems to have a very different impact on the epigenomes of frog
embryos and in vitro cultured murine ES cells.
Stage specific histone modification profiles
We have observed significant quantitative changes in a relatively
large number of histone modification states during frog embryo-
genesis. In order to investigate, whether particular developmental
stages could be described by characteristic groups of histone
modification states, we performed hierarchical clustering analysis
to identify potential epigenetic patterns, and we then generated a
Heatmap of the obtained clusters to visualize the results (Figure 6;
see Materials and Methods for details). The dendrogram on the
left axis of the Heatmap shows four well-defined clusters between
the second and third level. The most obvious features of the
heatmap are the four red-colored areas, each representing a
cluster of histone modifications at their individual maximal
abundance, which describe the four developmental stages that
we analysed. The separation is very clear between blastula and
tadpole clusters, where the red groups generally indicate a global
shift from active to repressive histone marks as the embryonic cells
undergo differentiation. It is less clear between gastrula and
neurula stages, in particular at the bottom third of the heatmap,
where several histone modification states persist at similar,
intermediate abundances until the tadpole stage. As gastrula and
neurula stages are biologically characterized by ongoing cellular
diversification, these modifications may be associated with
transitory features of germ-layer comitted precursor cell popula-
tions. Importantly, the apparent clustering provides unique
evidence for a global, stepwise maturation of the embryonic
epigenome in vertebrate embryos.
position 27 or 36, K27me2 = di-methylated lysine 27, K36me2 = di-methylated lysine 36, Kme3 = single tri-methylated lysine at position 27 or 36,
K27me1/K36me1 = double mono-methylated, K27me2/K36me2 = double di-methylated, K27me1/K36me2 = combinatorial triple-methylated
peptide with dimethlyted K36, K27me2/K36me1 = combinatorial triple-methylated peptide with dimethlyted K27. Error bars represent SD. Where
applicable, p values are given by numbers above brackets to indicate significant differences in the abundance of a histone modification between
samples.
doi:10.1371/journal.pone.0022548.g004
Global Transitions in Embryonic Epigenome
PLoS ONE | www.plosone.org 8 July 2011 | Volume 6 | Issue 7 | e22548H3K4 Methylation
unmod K4me1 K4me2 K4me3
0
60
50
40
30
10
20
0.001
0.0000001
0.00003
0.000004
0.00006
A
70
80
 Elution time
ES Cells
NF9 H3K27me2 H3K36me2
H3K27me2 H3K36me2
H3K27me2 H3K36me2
B
MEF
X
I
C
X
I
C
X
I
C
Elution time
ES Cells
NF9
me3
me3
H3K27me2 + K36me1
H3K27me2 + K36me1
H3K27me1 + K36me2
H3K27me1 + K36me2
MEF
me3
H3K27me2 + K36me1 H3K27me1 + K36me2
C
X
I
C
X
I
C
X
I
C
Blastula ES Cells
%
K27me1/
K36me1
K27me1/
K36me2
K27me2/
K36me1
K27me2/
K36me2
0
H3K27/K36 Methylation
2
4
6
40
10
30
20
E
0.001
0.003
0.007
0.01 %
unmod me1 K27
me2
K36
me2
K27
me3
0
10
50
70
30
D
%
K27
ac
        H3.1K27 and K36 
Methylation and Acetylation
1
0.0003
0.0001
0.0009
0.0004
0.04
0.01
0.0004
0.0002
0.0004
0.006
MEFs
0
1
2
NF9 NF37 ESC
50
100
200
300
400
500
H3K27me3 levels according to NF9
H3K27me3/H3 ratio
F         H3K27me3
       
NF9 NF37 ESC
anti-
H3K27me3
anti-panH3
0.0003
0.0002
0.007
0.04
0.003
0.0002
0.0003
0.03
0.03
0.0007
0.02
0.02
H3K4 Methylation
unmod K4me1 K4me2 K4me3
0
60
50
40
30
10
20
A
70
80
 Elution time
ells ES Ce S Cells
N NF9 H3K27me2 H3K36me2
H3K27me2 H3K27me2 H3K36me2 H3K36me2
H3K27me2 H3K36me2
B B
F MEF
X
I
C
X
I
C
X
I
C
Elution time
ES Cel
NF9
me3
me3
H3K27me2 + K36me1 me2 + K36m
H3K27me2 + K36me1
H3K27me1 +
H3K27me1 + 
MEF
me3
H3K27me2 + K36me1 me2 + K36m H3K27me1 +
C
X
I
C
X
I
C
X
I
C
Blastula B ES Cells
%
K27me1/
K36me1
K27me1/
K36me2
K27me2/
K36me1
K27me2/
K36me2
0
H3K27/K36 Methylation
2
4
6
40
10
30
20
E
00 1 %
unmod me1 K27
me2
K36
me2
K27
me3
0
10
50
70
30
D
%
K27
ac
        H3.1K27 and K36
Methylation and Acetylation
1
0.0003
0.0001
0.0004 4
MEFs
0
1
2
NF9 NF37 ESC
50
100
200
300
400
500
H3K27me3 levels according to NF9
H3K27me3/H3 ratio
F        H3K27me3
      
NF9 NF37 ESC
anti-
H3K27me3
anti-panH3
0.0003
0.0002
0.007
0.04
0.003
0.0002
0.0003
0.03
0.03
0.0007
0.02
0.02
Figure 5. Comparison of opposing histone modifications on histone H3 from Xenopus blastulae, murine ES cells and MEFs. A) Bar-
Charts showing H3K4 methylation states of X.laevis blastulae, GS-1 ES cells and mouse embryo fibroblasts. Data obtained by MALDI-TOF mass
spectrometry, error bars indicate SD of three independent biological replicates. B) XIC profiles of K27me2 and K36me2 modification states of the H3
27–40 peptide of X.laevis blastulae, murine ES Cells and MEFs on a C18 micro-column on a reversed-phase HPLC during Orbi-Trap on-line mass
spectrometry. C) XIC profiles for K27/K36me3, K27me2+K36me1 and K27me1+K36me2 of the H3 27–40 peptides from the same samples. In B and C,
x-axis gives relative elution times of peptides, the y-axis shows their intensity according to the ion current of the quadrupole Mass Spectrometer. InB
and C, X-axis represents retention time, y-axis the intensity of ion currents of the quadrupole Orbi-Trap mass spectrometer. Peak separation was
called by the ICIS peak detection algorithm program (Thermo), indicated here by vertical black lines. D) Bar-Chart of mutually exclusive H3K27 and
K36 methyl states. E) Bar-Chart of peptides with combinatorial H3K27 and K36 methylation. D and E - data from Orbi-Trap Mass Spectrometry, error
Global Transitions in Embryonic Epigenome
PLoS ONE | www.plosone.org 9 July 2011 | Volume 6 | Issue 7 | e22548Discussion
To our knowledge, this study represents the first description of
bulk histone modifications and their steady state flux as it occurs in
vivo during vertebrate embryogenesis. Using high accuracy LC-
MS/MS and MALDI-TOF mass spectrometry, we have detected
59 different modification states on 18 sites - all Lysine residues,
with the exception of histone H3 Serine 57 - derived from
canonical H3 and H4 histones. These results provide key insight
into global alterations of histone PTMs during development from
uncomitted cells of the late blastula to the differentiated tissues of
hatched, premetamorphic tadpoles.
Mass spectrometry is a very quantitative technique, as shown by
the proportionate increase in XICs upon loading of different
amounts of synthetic peptides (both unmodified and modified)
over several orders of magnitude [56]. In addition, we have
detected the full range of possible modifications for many peptides.
The modifications that we have not found are known to be either
of low abundance (Arginine methylation, Lysine ubiqitination) or
unstable (phosphorylation; see [57,58,59]. Finally, Western blots
for the H3K27me3 levels of frog embryos and ES cells confirm the
quantitative differences obtained by mass spec. Altogether, this
indicates that the reported relative abundances of modification
states are robust, and that it is very unlikely that they could be
inflated due to non-detected modifications.
At the time of germ layer induction, frog embryonic cells are
characterized by a low point of repressive histone modifications,
including H3K27me3. Our findings are in agreement with recent
ChIP-seq results from Xenopus tropicalis [22] and suggest that the
formation of somatic cell lineages in Xenopus species occurs from
an epigenetic state practically devoid of bivalent domains. Future
studies in Xenopus will have to address, whether the derepressed
state at blastula exists also in early pre-MBT stages such as the
morula (see also below). Global changes in histone modifications
occur in mouse embryos between fertilisation and the blastocyst
stage (reviewed in refs. [10,11]. However, histone PTMs have not
been investigated from post-implantation embryos, except for one
pioneering study using carrier ChIP [19]. Here, both K4me3 and
K27me3 marks were found on several developmental loci in
epiblast tissue, but the bivalent status of these loci was not
rigorously established and the opposing marks may derive from
distinct cell populations. Nevertheless, this study demonstrates that
K27me3 exists in the mouse embryo at the time of germ layer
formation, unlike in Xenopus embryos.
By hierarchical clustering analysis, we found that a large
fraction of the observed histone modifications fall into profiles that
apparently characterize each of the analysed embryonic stages.
This finding extends the hypothesis of individualized epigenomes
for different cell types (e.g. [15,20,21,60,61]) to whole embryos.
This surprising result does not necessarily imply that all cells of an
embryo at a given stage share the same histone PTM profile, but
rather reveals the existence of stage-specific constraints that shape
the histone modifications according to global cellular transitions,
such as the development from pluripotency to germ layer
precursor to committed and differentiated cell states. In line with
this hypothesis, the clearest differences are observed between
histones from post-MBT, uncomitted cells of blastulae (NF9) and
histones from the largely differentiated, somatic cells of tadpoles
(NF37). Overall, the four clusters describe a general decrease in
the abundance of active histone PTMs with a concomittant
increase of repressive histone modifications. For future experi-
ments, these clusters provide a blueprint of stage-specific
chromatin states that can be used to investigate the impact and
interrelationship of individual histone modifying enzymes.
We noted that some modification types - e.g. K9me1, K14ac,
K36me2 on histone H3, or K16ac on histone H4 - remained
remarkably constant (,two-fold changes) over this time course.
Even though the local distribution of the PTMs at these histone
residues will vary between cell types, this finding suggests relatively
static or basic functions for them. For other sites, the steady state of
PTMs can change very strongly within few hours, most notably
between the late blastula and midgastrula stages. Here, the largest
differences were observed on histone H3 for K27me1/K36me1
and K27me1/K36me2 (18-fold and 9.8-fold increase, respective-
ly), as well as for acetylation and mono-methylation of H3K56
(11.5-fold and 18-fold decrease, respectively). Another example is
represented by double-acetylation of Lysines 8 and 16 on H4,
which rises from below detection limit to 11% abundance within
this short time window. The disproportionate change in the steady
state of these specific PTMs suggests that they are regulated by
some developmental mechanism, possibly involving the signalling
cascades that drive embryonic induction and cell differentiation.
Since Lysines 27 and 36 are present on the same tryptic peptide,
it was possible to distinguish a total of 12 different modification
states. Specifically, almost half of the unmodified fraction of this
peptide becomes modified in steady state between blastula and
gastrula. This dramatic increase in K27 methylation is consistent
with the results of recent ChIP-studies in X. tropicalis and D. rerio,
which reported a hierarchical acquisition of H3K4 and K27
methyl marks [22,23]. In extension to these studies, however, we
have found that the K27me3 mark is at least 100-fold less
abundant in Xenopus early embryos than in cultured frog or
mammalian cell lines, including murine ES-cells. As a conse-
quence, the K27me3 density in chromatin may be rather low
throughout the embryo. Alternatively, it could be high within a
subfraction of either cells or genomic regions, and consequently
being depleted from the rest. Whatever may be the case, this
finding is very unexpected, given current models on the epigenetic
nature of pluripotency. Functional tests are required to clarify,
whether at this low abundance (,0.1%) H3K27me3 represses
transcription in Xenopus blastulae as reported for human and
murine ES cells, in which H3K27me3 is much more abundant
(refs. [1,15,62]; and our data here).
It is not known, why the chromatin of the frog blastula is so
devoid of the H3K27me2/me3 marks. Recently, an antagonistic
relationship between methylation and acetylation of Lysine 27 has
been reported that reflects a competition between PcG and
trithorax/MLL complexes, which recruit H3K27 methyltransfer-
ase or acetyltransferase activities, respectively [63]. Since frog
embryos contain the highest relative K27ac levels in our data set,
one might speculate that some regulatory mechanism in blastula
embryos favors MLL-mediated recruitment of HATs. However, a
direct competition between trx and PcG proteins on target genes is
unlikely to explain entirely the initial depletion in H3K27
bars indicate SEM of two independent biological replicates. F) Immunoblotting for total histone H3 and histone H3 trimethylated at lysine 27. Upper
panel – western blot Odyssey infrared imaging signals; lower panel – bar chart showing the abundance of H3K27me3 levels relative to total histone
H3 protein in Blastulae (NF9), Tadpoles (NF37) and murine GS-1 ES cells. Abbr.: unmod = unmodified peptide, Kme1 = mono-methylated lysine
residue, Kme2 = di-methylated lysine residue, Kme3 = tri-methylated lysine residue. Where applicable, p values are given by numbers above
brackets to indicate significant differences in histone modifications between samples.
doi:10.1371/journal.pone.0022548.g005
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development despite the dramatic increase in K27me2/me3 from
gastrula stages onwards.
Nicklay and colleagues have incubated sperm nuclei with
Xenopus egg extract in vitro to generate chromatin of ‘‘early
embryo equivalent’’ that may represent the chromatin state before
or at MBT [21]. This sample contains quite abundant K27me3
levels (estimated 10–50%), confirming the maternal expression of
biologically active PRC2 components in early embryos [64].
However, neither we (this study) nor others [22] have found
evidence for this in NF9 blastulae. If chromatin of the ‘‘early
embryo equivalent’’ corresponds to a physiological state, one
would have to postulate that practically all K27me3 marks become
erased before midblastula. The presence of maternal and
potentially active PRC2 complexes in turn suggests for the
unmanipulated frog embryo that PRC2 activity is either negatively
controlled or efficiently antagonized by demethylation [65] around
the onset of zygotic transcription. The sudden increase of K27me2
at gastrula suggests a regulatory switch that quite rapidly brings a
significant portion of the epigenome under the influence of the
polycomb system. This switch may include the upregulation of
Suz12 mRNA levels that has been described during gastrulation
[64].
During the amphibian blastula-gastrula transition, pluripotent
embryonic cells are programmed by induction to germ layer
related cell fates [28,29]. This phase corresponds in mammalian
embryos to the specification of the epiblast at implantation, from
when on pluripotency is gradually lost [66]. Although being low
abundant, acetylation of H3K56 is specifically enriched at
promoters bound by the core pluripotency factors Oct4/Sox2/
Nanog. When ES cells differentiate, K56ac relocates to develop-
mental regulatory genes [45]. We have found that K56ac levels
drop more than ten-fold between blastula and gastrula (Figure 2
and Table S1). It is possible that the transient depletion of K56ac
from gastrula chromatin reflects the reported translocation of this
mark, when pluripotency is lost in ES cells, and possibly in
mammalian embryos. At the same time, the embryonic K9me1
level rises to a transient maximum of 20% abundance. H3K9me1
has been recognized as a stable mark of cis-regulatory elements for
both active and inactive genes [1]. Together, the observed changes
in the H3K56ac and H3K9me1 profiles may thus be important for
the programming of cell fates.
The extraordinary abundance of H3K4me3 (almost 30%) in
frog blastulae represents another puzzling observation. In
mammals, the H3K4me3 mark is found on gene promoters and
enhancers. Given that frog and human genomes are comparable
in size and gene numbers, this level exceeds the expected genome
proportion represented by these transcriptional regulatory ele-
ments. Notably, murine ES cells have similarly high levels, and
even in somatic cells (A6, XTC and MEFs) its abundance is
around 10% (see Figures 2, 5 and S3). Due to the unusual
biophysical properties of this peptide, we could not record MS2
events, which would have allowed us to distinguish acetylated and
trimethylated states. Although H3K4 acetylation levels are
generally low [47], it is possible that some fraction of the
H3K4me3 peak represents acetylated peptides. Nevertheless, one
may speculate that H3K4me3 could be deposited differently in
embryonic cells compared to somatic cells. In addition to the
typical promoter-proximal peaks, which have been observed in
recent genome-wide ChIP experiments both in Xenopus [15] and
zebrafish [16], this mark could exist at higher base-levels
throughout the embryonic epigenome, and/or be enriched
significantly in still unannotated areas. The high abundance of
H3 K4me3 in embryos certainly merits further investigation.
In general, the HMP of the frog blastula describes a highly
permissive chromatin environment at the time of embryonic
induction that is remarkably devoid of repressive methyl marks on
H3K9, H3K27 and H4K20. This transcriptionally permissive
epigenome may mechanistically explain, why some region or cell-
type specific genes are initially activated in apparently ectopic
manners in frog embryos [67,68]. Subsequent refinement of gene
expression patterns during gastrulation requires de novo synthesis of
repressors [69], possibly including epigenetic repressors such as the
PRC2 component Suz12 [64]. Based on our data, and on ChIP-
Seq derived genome wide maps for H3K4 and H3K27 methyl
marks [22], the epigenetic state of pluripotent Xenopus embryonic
cells can thus be defined as ‘‘active’’ and ‘‘derepressed’’. In this
sense, they differ significantly from pluripotent mammalian ES
cells and early post-implantation mouse embryos, which contain
represssive marks such as H3K27me3 (our data on GS1-ES cells;
[12,19,55] ). Our findings with Xenopus embryos underscore the
necessity to further explore the epigenetic ground state of
pluripotency in primary cells.
Materials and Methods
Ethics Statement
Animal work has been conducted in acordance with Deutsches
Tierschutzgesetz; experimental use of Xenopus embryos has been
licenced by the Government of Oberbayern (Projekt/AZ ROB:
211-2531.6-11/2001).
Embryos and cell lines
Embryos were generated by in vitro fertilization with adult
X.laevis animals (Nasco, Xenopus Express) as described [54]. Stable
cell lines A6 (derived from adult frog kidney tissue) [70] and XTC-
2 (derived from Xenopus tadpole carcass) [71] ) were grown in
75% DMEM supplemented with 10% FCS, 100 u/ml penicillin/
100 ng/ml streptomycin at 26uC in a humidified atmosphere with
5% CO2.
Murine embryonic fibroblasts were isolated from ICR mice at
day 13 of pregnancy and subsequently grown in DMEM, 10%
FCS, 2 mM L-glutamine, 50 U/ml penicillin, 50 mg/ml strepto-
mycin. For chromatin analysis, non inactivated MEFs at passage 2
were used. Murine GS-1 ES cells were grown on inactivated MEFs
(3 hrs. 8 mg/ml mitomycin C) in high glucose Dulbecco’s modified
Eagle medium supplemented with 10% heat-inactivated ES-
qualified fetal calf serum, 2 mM L-glutamine, 50 U/ml penicillin,
50 mg/ml streptomycin, 1x nonessential amino acids (all reagents
GIBCO BRL, Germany) and 0.1 mM ß-mercaptoethanol (Sigma,
Germany). For chromatin analysis, the ES cells were transferred to
feeder free conditions on gelatinated plates for three passages to
avoid contamination of probe material with MEF derived
chromatin. During feeder-free culture, ES cells were kept
Figure 6. Stage-specific histone modification profiles. The heatmap visualizes clusters of histone modifications according to their relative
abundance at the four developmental stages, which we have investigated. The hierarchical clustering analysis produces a dendrogram, shown on the
left side, with four major branches that correspond to specific developmental stages. Modifications associated with transcriptional activity are
highlighted in green, while modifications associated with repressed/silent states are shown in magenta. The four clusters define histone
modifications profiles (HMPs), which reflect the gradual transition from uncomitted to determined cell fates.
doi:10.1371/journal.pone.0022548.g006
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mouse leukemia inhibitory factor (ESGRO; Life Technologies,
Inc., Grand Island, N.Y.) to the medium. Monolayers were
passaged by trypsinization at 70–80% confluency and the cells
were maintained at 37uC in a humidified atmosphere of 5% CO2/
95% air.
Histone Extraction
Around 50 to 100 embryos developed to Blastula (NF9, 7 hpf),
Gastrula (NF12, 13 hpf), Neurula (NF18, 20 hpf), and Tadpole
(NF37, 54 hpf) stages were harvested and washed with 110 mM
KCl, 50 mM Tris/HCl (pH 7.4 at 23uC), 5 mM MgCl2, 0.1 mM
spermine, 0.1 mM EDTA, 2 mM DTT, 0.4 mM PMSF, 10 mM
Na-butyrate. Nuclei of the embryos were prepared by centrifuga-
tion with 2600xg, 10 min (3–18, Sigma) after homogenization by a
5 ml glass-glass douncer (Braun, Melsungen). For cell lines, 10
7
cells were collected and washed twice with 1 ml PBS, 0.1 mM
spermine, 0.1 mM EDTA, 2 mM DTT, 0.4 mM PMSF, 10 mM
Na-butyrate and then resuspended in 1 ml PBS buffer containing
0.3% Triton. The cells were put on a rotating wheel at 4uC for
20 min and then centrifuged with an Eppendorf Centrifuge 5417C
with top speed. The supernatent containing the cytoplasmatic
fraction was discarded. The nuclear pellets of both Xenopus
embryos and cell lines were resuspended in 1 ml 0.4 M HCl,
incubated on a rotating wheel over night and dialysed against 3l of
0.1 M acetic acid/1 mM DTT. The dialysed histone solution was
vacuum-dried in a Concentrator Plus (Eppendorf) and stored at
220uC.
Mass Spectrometry
Histones were separated by sodium dodecyl sulfate-polyacryl-
amide gel electrophoresis (SDS-PAGE). Coomassie blue-stained
bands were excised and propionylated as described before [34].
Digestions were carried out overnight with 200 ng sequencing
grade trypsin (Promega); Before analysis, the peptide solution was
desalted using Zip-Tips (Millipore) or porous carbon material
(TipTop Carbon, Glygen). Bound pepties were eluted in matrix
solution (saturated -cyanohydroxycinnamic- acid [Sigma] dis-
solved in 50% acetonitril [vol/vol], 0.3% trifluoroacetic acid [vol/
vol]) and spotted onto a target plate. The target plate was loaded
in a Voyager DE STR spectrometer (Applied Biosystems). The
resulting spectra were analyzed using the Data Explorer and in-
house-developed software Manuelito (open source: http://source-
forge.net/projects/manuelito ). For quantification of the different
post-translational modifications of the various peptides, the relative
intensities of each were measured. The areas of all modifications of
one peptide were summarized and thus the percentage of each
modification was calculated. The statistical significance of
quantitative changes during development or between samples
was determined by Student’s T-test.
For LC-MS/MS analysis the digested histones were loaded onto
a reversed-phase HPLC in an analytical C18 column (75 mm i.d
packed with C18 PepMap
TM,3mm, 100A ˚ by LC Packings) and
eluted using a 80 min gradient from 5 to 60% ACN in 0.1% FA.
Spectra were recorded by a LTQ-Orbitrap mass spectrometer
operating in a top six mode where the six most intense peptide ions
with charge states between 2 and 4 were sequentially isolated and
fragmented in the linear ion trap by collision-induced dissociation
(CID). All fragment ion spectra were recorded in the LTQ part of
the instrument. For all measurements with the orbitrap detector, 3
lock-mass ions from ambient air (m/z=371.10123, 445.12002,
519.13882) were used for internal calibration as described. Typical
mass spectrometric conditions were: spray voltage, 1.5 kV; no
sheath and auxiliary gas flow; heated capillary temperature 200uC.
For the analysis of different histone modifications the resulting
RAW files were converted into DTA and searched against the
NCBI non-redundant database using the SEQUEST search
algorithm to identify the corresponding histones using the
BIOWORKS3.3 software package (Thermo). In order to
determine the posttranslational modifications on the histone
peptides, the data files were searched against a targeted histone
database containing Xenopus laevis histone molecules from the
NCBI non-redundant database by SEQUEST search algorithm
with the following modification settings (static modification on
lysine: 56.0262; variable modifications: me1: 14.01565; me2: -
27.99490; me3: -13.97925; ac: -14.10565 on K and phos:
79.96633 on S). The resulting SEQUEST files were filtered for
a peptide probability score of 0.0005 and Xcorrelation values of
1.5, 2.0, 2.5 and 3 for charge states 1, 2, 3 and 4 accordingly. A
similar search against a reversed and scrambled histone decoy
database did not lead to an identification of peptides that matched
the filter criteria. Therefore we estimated the false discovery rate to
be less than 1%. For quantification, only modifications with a
probability score of lower than 0.0005 and top hits were used. For
all peptides, which were quantified, an extracted ion chromato-
gram (XIC) was obtained from the raw file using the Xcalibur
2.0.7 software using the default ICIS peak detection algorithm
(Thermo), extracting doubly and triply charged ions with a user
defined mass tolerance of 5–10 ppm and a mass precision of 4
decimals to be able to distinguish between nominally isobaric
modifications such as acteylation or trimethylation. The retention
time for each specific peptide on the chromatography was highly
specific when we used the same LC MS/MS method. We
therefore only used these XIC areas for quantification, which
eluted at time points where we observed at least two MS/MS
spectra that unambiguously identified the identity of the peptide
and the position of the modification within the peptide.
Quantitative Western blotting
Western blot analysis for H4 K20me3 was carried out according
to standard protocols [72]. Nuclei of 0.5–2 embryo equivalents
were used, depending on developmental stage. After SDS-PAGE,
proteins were blotted with 1.5 mA/cm2 for 1 h to nitrocellulose
membranes (porcello NCL, Macherey-Nagel), which were blocked
for 1 h using PBS, 3% BSA. Primary antibodies detecting
H3K27me3 (1:3 000; ref. [73]), H4K20me3 (1:500; ref. [73]) or
core region-H3 (Abcam, 1:25.000) were incubated using PBS, 3%
BSA. Secondary fluorophore linked antibody (Li-cor, IRDye
700DX goat anti-rabbit, 1:5 000) was incubated in PBS, 5% Milk
powder, 0.1% Tween 20. Fluorescent signals were recorded using
Li-cor Odysse wet membrane technique for 700 nm absorbance.
Heatmap Generation
We generated the Heatmap shown in Figure 6 using R (http://
www.r-project.org) and the gplots package (http://CRAN.R-
project.org/package=gplots). All functions were called using
default parameters if not indicated otherwise. We first calculated
the mean and the standard deviation of the quantifications
obtained by Mass Spectometry across the four developmental cell
stages (each stage containing two biological replicates) for each of
the 57 modifications. Histones with small mean values contain low
Mass Spectometry quantifications that could obscure the cluster-
ing analysis that we observe in the heatmap. Thus, as a
preprocessing step of the data, we discarded modifications with
mean values less than 0.5% (22 modifications). In order to
compare appropriately the contribution of each modification to
the specific cell stages, we standardized the mass spectometry
quantifications individually using Z-scores. Using these Z-scores
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variance method to perform the hierarchical clustering analysis.
Supporting Information
Figure S1 Conservation of nucleosomal core histone
sequences. ClustalW alignment of core nucleosomal histone
proteins from Xenopus, human, mouse and Drosophila. Genbank
accession numbers of Xenopus proteins – H3.2 (AAA49770), H3.3
(NP_001080065), H4 (AAA49771).
(EPS)
Figure S2 Histone modification sites and sequence
coverage of Xenopus histones H3 and H4 after tryptic
digest. Underlined are the amino acid sequences analyzed here
by Mass Spectrometry. Amino acid residues known to be
covalently modified in mammalian histones (see Bhaumik et al.,
2010) are 100% conserved in frog histones and shown in bold
letters. Histone H3.2 and H3.3 sequences differ in few positions,
one of which (position 30 - Serin in H3.3 versus Ala in H3.2) is
present on the peptide H3 27–40. Mass spec data refers to histone
H3.2, which is much more abundant than H3.3.
(EPS)
Figure S3 Histone modification patterns of Xenopus
somatic cell lines. Bar-Charts displaying the relative abun-
dance of histone modifications from Xenopus somatic cell lines A6
and XTC-2 (see color code in panel F). Panels A–D, G and I–K
show data from Orbi-Trap Mass Spectrometry; error bars indicate
SD of two independent biological replicates. Panels E and H
contain MALDI-TOF data; error bars indicate SD of three
independent biological replicates. Abbr.: unmod = unmodified
peptide, Kac = acetylated lysine residue, Kme1 = mono-
methylated, Kme2 = di-methylated, Kme3 = tri-methylated
lysine residues. Where applicable, p values are given by numbers
above brackets to indicate significant differences in histone
modifications between cell types.
(EPS)
Figure S4 H4K20me3 levels in cultured mammalian
and frog cells. Immunoblotting for total histone H3 and histone
H4 trimethylated at lysine 20. Upper panel – western blot Odyssey
infrared imaging signals; lower panel – bar chart showing the
abundance of H4K20me3 levels relative to total histone H3
protein in murine GS-1 ES cells, MEFs and Xenopus cell lines A6
and XTC. Error bars (SD).
(EPS)
Figure S5 Quantification of H3.3/H3.2 ratios in Xeno-
pus bulk histones isolated from different developmental
stages. The ratios of MS/MS events for the unique H3.3 peptide
KSAPSTGGVKKPHR and the corresponding H3.2 peptide
KSAPATGGVKKPHR were calculated and used as a proxy to
determine the ratio of H3.3/H3.2 in histones isolated from various
embryo samples. Abbreviations: NF9 =Blastula, NF12 =
Gastrula, NF18 = Neurula, NF37 = Tadpole, A6 - frog kidney
cell line. Values represent the mean of at least two independent
biological replicates. Error bars represent the calculated SD
values.
(EPS)
Figure S6 Distinct histone modification patterns reveal
adequate separation of murine ES cells from MEF-
feeder cells. Bar-Charts for acetylated histones H4 4–17 (A) and
H3 18–26 (B) peptides. Data from Orbi-Trap Mass Spectrometry,
error bars indicate SD of two independent biological replicates.
Numbers above brackets provide p-values for quantitative
differences between ES and feeder cells. C) Murine GS-1 ES cells
cultured on c-irradiated MEF feeder cell layer. D) GS-1 ES cells
after two passages with recombinant LIF-supplemented medium
without feeder cells.
(EPS)
Table S1 Tandem Mass Spectrometry - quantitative
results of histone H3 modifications. Indicated is the peptide
with its amino acid sequence, its different modifications and their
masses (M(cal)H+), and the percentile value of the modification
according to the LC quantification. Abbreviations: NF9 =
Blastula stage, NF12 = Gastrula stage, NF18 = Neurula stage,
NF37 = Tadpole stage, A6 and XTC-2 are stable X.laevis cell
lines, ES: murine GS-1 ES cell line, MEFs = murine embryo
fibroblasts. M(cal)H+ is the mass of the positively charged peptide,
Av. RT is the average Retention time of the peptide on the C18
micro colum of the reversed-phase LC-MS. Values represent the
mean of two independent biological replicates.
(EPS)
Table S2 Tandem Mass Spectrometry - quantitative
results of histone H4 modifications. Indicated is the eptide
with its amino acid sequence and the different modifications and
their masses (M(cal)H+) and the percentile value of the
modification according to the LC quantification. Abbr.: NF9 =
Blastula stage, NF12 = Gastrula stage, NF18 = Neurula stage,
NF37 = Tadpole stage, A6 and XTC are stable X.laevis cell lines,
ES: murine GS-1 ES cell line, MEFs = murine embryo
fibroblasts. M(cal)H+ is the mass of the positively charged peptide,
Av. RT is the average Retention time of the peptide on the C18
micro colum of the reversed-phase LC-MS. Values represent the
mean of two independent biological replicates.
(EPS)
Table S3 Tandem Mass Spectrometric MS2 events after
Collision Induced Dissociation (CID) of Histone H3.
Indicated is the peptide with its amino acid sequence and the
different modifications and their masses (M(cal)H+) and the
number of MS2 events for each modification. Numbers highlight-
ed in grey are not used for quantification as their peptide
probability score was lower than other modifications of the same
modification state. Abbreviations: NF9 = Blastula stage, NF12 =
Gastrula stage, NF18 = Neurula stage, NF37 = Tadpole stage.
A6 and XTC are stable X.laevis cell lines; ES: murine GS-1 ES cell
line, MEFs = murine embryo fibroblasts. ‘‘M(cal)H+’’ is the mass
of the positively charged peptide. ‘‘Av DeltaM’’ lists the average
mass deviation of the theoretical mass and the measured values.
‘‘Av RT’’ describes the average retention time of the peptide on
the C18 micro-column of the reversed-phase LC-MS. ‘‘z’’ is the
charge of the most abundant peptide. Values represent the mean
of two independent biological replicates.
(EPS)
Table S4 Tandem Mass Spectrometric MS2 Events
after Collision Induced Dissociation (CID) of Histone
H4. Indicated is the peptide with its amino acid sequence and the
different modifications and their masses (M(cal)H+) and the
number of MS2 events for each modification. Numbers highlight-
ed in grey are not used for quantifications as their peptide
probability score was lower than other modifications of the same
modification state. Abbreviations: NF9 = Blastula stage, NF12 =
Gastrula stage, NF18 = Neurula stage, NF37 = Tadpole stage,
A6 and XTC-2 are stable X.laevis cell lines, ES: murine GS-1 ES
cell line, MEFs = murine embryo fibroblasts. ‘‘M(cal)H+’’ is the
mass of the positively charged peptide. ‘‘Av DeltaM’’ lists the
average mass deviation of the theoretical mass and the measured
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peptide on the C18 micro-column of the reversed-phase LC-MS.
‘‘z’’ is the charge of the most abundant peptide. Values represent
the mean of two independent biological replicates.
(EPS)
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